Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How do the carbon and nitrogen sources affect the synthesis of β-(1,3/1,6)-glucan, its structure and the susceptibility of Candida utilis yeast cells to immunolabelling with β-(1,3)-glucan monoclonal antibodies?
Bzducha-Wróbel A, Farkaš P, Bieliková S, Čížová A, Sujkowska-Rybkowska M. Bzducha-Wróbel A, et al. Among authors: farkas p. Microb Cell Fact. 2024 Jan 19;23(1):28. doi: 10.1186/s12934-024-02305-4. Microb Cell Fact. 2024. PMID: 38243245 Free PMC article.
MXene-based electrochemical devices applied for healthcare applications.
Lorencova L, Kasak P, Kosutova N, Jerigova M, Noskovicova E, Vikartovska A, Barath M, Farkas P, Tkac J. Lorencova L, et al. Among authors: farkas p. Mikrochim Acta. 2024 Jan 11;191(2):88. doi: 10.1007/s00604-023-06163-6. Mikrochim Acta. 2024. PMID: 38206460 Free PMC article. Review.
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
László T, Kotmayer L, Fésüs V, Hegyi L, Gróf S, Nagy Á, Kajtár B, Balogh A, Weisinger J, Masszi T, Nagy Z, Farkas P, Demeter J, Istenes I, Szász R, Gergely L, Sulák A, Borbényi Z, Lévai D, Schneider T, Pettendi P, Bodai E, Szerafin L, Rejtő L, Bátai Á, Dömötör MÁ, Sánta H, Plander M, Szendrei T, Hamed A, Lázár Z, Pauker Z, Radványi G, Kiss A, Körösmezey G, Jakucs J, Dombi PJ, Simon Z, Klucsik Z, Gurzó M, Tiboly M, Vidra T, Ilonczai P, Bors A, Andrikovics H, Egyed M, Székely T, Masszi A, Alpár D, Matolcsy A, Bödör C. László T, et al. Among authors: farkas p. J Pathol Clin Res. 2024 Jan;10(1):e351. doi: 10.1002/cjp2.351. Epub 2023 Nov 21. J Pathol Clin Res. 2024. PMID: 37987115 Free PMC article.
[How did the survival of acute myeloid leukemia change over the last ten years in our unit?].
Gaál L, Ruff E, Wiedemann Á, Svorenj S, Szita VR, Tóth AD, Masszi A, Horváth L, Szombath G, Nagy Z, Várkonyi J, Benedek S, Farkas P, Bödör C, Masszi T, Varga G. Gaál L, et al. Among authors: farkas p. Orv Hetil. 2023 Nov 12;164(45):1787-1794. doi: 10.1556/650.2023.32901. Print 2023 Nov 12. Orv Hetil. 2023. PMID: 37952177 Hungarian.
Model-Informed Drug Development: Steps Toward Harmonized Guidance.
Marshall S, Ahamadi M, Chien J, Iwata D, Farkas P, Filipe A, Frey N, Greene E, Kawai N, Li J, Lippert J, Musuamba Tshinanu F, Manolis E, Peterson MC, Sarem S, Shebley M, Tegenge M, Tsai CH, Tu CL, Otsubo Y, Wei J, Zhang L, Zhu H, Karlsson KE. Marshall S, et al. Among authors: farkas p. Clin Pharmacol Ther. 2023 Nov;114(5):954-959. doi: 10.1002/cpt.3006. Epub 2023 Aug 3. Clin Pharmacol Ther. 2023. PMID: 37534711 No abstract available.
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Kotmayer L, László T, Mikala G, Kiss R, Lévay L, Hegyi LL, Gróf S, Nagy T, Barna G, Farkas P, Weisinger J, Nagy Z, Balogh A, Masszi T, Demeter J, Sulák A, Kohl Z, Alizadeh H, Egyed M, Pettendi P, Gergely L, Plander M, Pauker Z, Masszi A, Matolcsy A, Szász R, Bödör C, Alpár D. Kotmayer L, et al. Among authors: farkas p. Int J Mol Sci. 2023 Mar 18;24(6):5802. doi: 10.3390/ijms24065802. Int J Mol Sci. 2023. PMID: 36982875 Free PMC article.
109 results